Actively Recruiting
Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery
Led by Charles University, Czech Republic · Updated on 2026-01-06
200
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The Medtrum TouchCare Nano system with the APGO algorithm is the only patch pump-based automated insulin delivery system available in the Czech Republic. However, until now, no prospective clinical study has evaluated its efficacy and safety under real-world conditions. The RENEW study is the first to address this topic.
CONDITIONS
Official Title
Efficacy and Safety of the APGO Algorithm for Automated Insulin Delivery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients diagnosed with Type 1 Diabetes
- Having Type 1 Diabetes for at least 1 year
- Age 18 years or older
- Provided written informed consent before starting the study
You will not qualify if you...
- Severe noncompliance with medical instructions
- Currently pregnant, breastfeeding, or planning pregnancy during the study
- Using medications that affect carbohydrate metabolism
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
3rd Department of Internal Medicine, 1st Faculty of Medicine, Charles University, Prague, Czechia
Prague, Czechia
Actively Recruiting
Research Team
J
Jan Soupal
CONTACT
D
Dat Do
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here